Sarcoma Alliance,
Doubling the dose of the targeted treatment #ripretinib (#QINLOCK) from once to twice a day may result in longer survival times…
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
Overview of attention for article published in Oncologist, August 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (86th percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Readers on
- mendeley
- 28 Mendeley